A simple practice guide for dose conversion between animals and human

Reigner, 2002, Eur J Clin Pharmacol, Estimating the starting dose for entry into humans: Principles and practice, 835

Contrera, 2004, Regul Toxicol Pharmacol, Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose, 185

Lavé T, Luttringer O, Poulin P, Parrott N. Interspecies scaling. In: Krishna R, editor. Applications of Pharmacokinetic Principles in Drug Development. New York: Springer Science and Business Media, LLC; 2004. p. 133-75.

Sharma, 2009, Br J Pharmacol, To scale or not to scale: The principles of dose extrapolation, 907

Chaturvedi, 2001, Curr Opin Chem Biol, Prediction of pharmacokinetic properties using experimental approaches during early drug discovery, 452

Rhomberg, 2006, Hum Ecol Risk Assess, Methods for identifying a default cross-species scaling factor, 1094

USFDA. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Adult Healthy Volunteer. Rockville, MD: US Food and Drug Administration; 2005.

Banavar, 2010, Proc Natl Acad Sci U S A, A general basis for quarter-power scaling in animals, 15816

White, 2014, Compr Physiol, Metabolic scaling in animals: Methods, empirical results, and theoretical explanations, 231

Lowe, 2010, Basic Clin Pharmacol Toxicol, On setting the first dose in man: Quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models, 195

Shin, 2010, J Korean Orient Med, Interpretation of animal dose and human equivalent dose for drug development, 1

Zou, 2012, AAPS J, Applications of human pharmacokinetic prediction in first-in-human dose estimation, 262

Animal Care and Use Program, Duke University and Medical Center. Available from: . [Last accessed on 2015 Oct 01].